1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JC; Chen, YT; Chiou, WC; Huang, C; Hwang, LH; Lyu, YS; Yang, HY; Yang, JM | 1 |
1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
Topics: Binding Sites; Catechin; Coronavirus 3C Proteases; COVID-19; Drug Evaluation, Preclinical; Humans; Hydrolyzable Tannins; Kinetics; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Pandemics; Protease Inhibitors; Protein Binding; Protein Domains; SARS-CoV-2; Virus Replication | 2022 |